ReNeuron Group PLC
LSE:RENE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
ReNeuron Group PLC
LSE:RENE
|
UK |
Balance Sheet
Balance Sheet Decomposition
ReNeuron Group PLC
ReNeuron Group PLC
Balance Sheet
ReNeuron Group PLC
| Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
15
|
12
|
17
|
28
|
28
|
20
|
13
|
15
|
10
|
6
|
|
| Cash |
15
|
12
|
17
|
28
|
28
|
20
|
13
|
15
|
10
|
6
|
|
| Short-Term Investments |
6
|
0
|
43
|
25
|
10
|
6
|
0
|
8
|
5
|
1
|
|
| Total Receivables |
1
|
1
|
4
|
5
|
4
|
4
|
6
|
2
|
2
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
22
|
14
|
65
|
58
|
42
|
30
|
19
|
24
|
16
|
9
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
3
|
2
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
|
| Intangible Assets |
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
24
N/A
|
16
-33%
|
72
+347%
|
59
-18%
|
43
-26%
|
32
-27%
|
20
-35%
|
25
+24%
|
17
-32%
|
10
-44%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
2
|
2
|
6
|
7
|
2
|
2
|
1
|
0
|
|
| Accrued Liabilities |
1
|
1
|
2
|
4
|
0
|
0
|
4
|
4
|
6
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
2
|
4
|
6
|
6
|
7
|
6
|
6
|
7
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Other Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
3
+23%
|
4
+42%
|
6
+36%
|
7
+20%
|
8
+21%
|
7
-14%
|
6
-10%
|
7
+15%
|
5
-38%
|
|
| Equity | |||||||||||
| Common Stock |
18
|
18
|
32
|
32
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Retained Earnings |
42
|
51
|
62
|
76
|
61
|
75
|
85
|
96
|
105
|
109
|
|
| Additional Paid In Capital |
46
|
46
|
98
|
98
|
98
|
98
|
98
|
114
|
114
|
114
|
|
| Total Equity |
22
N/A
|
13
-40%
|
68
+415%
|
53
-21%
|
37
-31%
|
23
-36%
|
13
-43%
|
19
+43%
|
10
-48%
|
5
-49%
|
|
| Total Liabilities & Equity |
24
N/A
|
16
-33%
|
72
+347%
|
59
-18%
|
43
-26%
|
32
-27%
|
20
-35%
|
25
+24%
|
17
-32%
|
10
-44%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
18
|
18
|
33
|
33
|
33
|
33
|
33
|
57
|
57
|
57
|
|